ArticleScientific reports2026
Hybrid deep learning framework for accurate classification of high dimensional genomic data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-dimensional genomic datasets often contain redundant, noisy, and sparse features that make accurate classification challenging for conventional deep learning (DL) models. Existing approaches generally fail to maintain interpretability and stability when confronted with heterogeneous genomic structures. To address these limitations, this study proposes a hybrid TabNet-CNN framework that combines attention-driven feature selection with adaptive convolutional refinement. The attention mechanism in TabNet highlights the most relevant genomic attributes, while the convolutional layers enhance localized feature interactions for accurate decision boundaries. Experimental results on multiple genomic datasets demonstrate superior performance in accuracy, AUC, and interpretability compared to state-of-the-art models. The proposed framework holds promise for real-world applications such as biomarker identification, disease subtyping, and clinical decision-support systems in precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.